Relative contribution of target gene mutation and efflux to fluoroquinolone and erythromycin resistance, in French poultry and pig isolates of Campylobacter coli

International Journal of Antimicrobial Agents

Volumn 23, Issue 5, 2004, Pages 468-472

  Payot, Sophie ^a   Avrain, Laetitia ^b   Magras, Catherine ^c   Praud, Karine ^a   Cloeckaert, Axel ^a   Chaslus Dancla, Elisabeth ^a  

^a CEMAGREF   (France)

^b Healthy Pigs Production and Experimentation Section   (France)

^c Ecole Nationale d'Ingenieurs des Techniques des Industries Agricoles et Alimentaires ENITIAA   (France)

Author keywords

Campylobacter; Efflux; Erythromycin; Fluoroquinolone; Inhibitor; Mutation

Indexed keywords

AMIDE; AMPICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; ENROFLOXACIN; ERYTHROMYCIN; PHENYLALANYLARGINYL BETA NAPHTHYLAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CAMPYLOBACTER COLI; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POULTRY; PRIORITY JOURNAL; SWINE;

AMINO ACID SUBSTITUTION; ANIMALS; BACTERIAL PROTEINS; BIOLOGICAL TRANSPORT; CAMPYLOBACTER COLI; DIPEPTIDES; DNA FINGERPRINTING; DNA GYRASE; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; ERYTHROMYCIN; FLUOROQUINOLONES; FOOD MICROBIOLOGY; FRANCE; GENES, BACTERIAL; GENES, RRNA; MEMBRANE TRANSPORT MODULATORS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POULTRY; RNA, RIBOSOMAL, 23S; SWINE;

EID: 2342652248     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2003.12.008     Document Type: Article

References (31)

1. Friedman CR, Neimann J, Wegener HC, Tauxe RV. Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations. In: Nachamkin I, Blaser MJ, editors. Campylobacter. Washington: American Society for Microbiology; 2000. p. 121-38.
2. Jacobs-Reitsma WF. Campylobacter in the food supply. In: Nachamkin I, Blaser MJ, editors. Campylobacter. Washington, DC: American Society for Microbiology; 2000. p. 467-81.
3. Skirrow MB, Blaser MJ, Clinical aspects of Campylobacter infection. In: Nachamkin I, Blaser MJ, editors. Campylobacter. Washington, DC: American Society for Microbiology; 2000. p. 69-88.
4. Pedersen K., Wedderkopp A. Resistance to quinolones in Campylobacter jejuni and Campylobacter coli from Danish broilers at farm level. J. Appl. Microbiol. 94:2003;111-119
5. Pezzotti G., Serafin A., Luzzi I., Mioni R., Milan M., Perin R. Occurrence and resistance to antibiotics of Campylobacter jejuni and Campylobacter coli in animals and meat in northeastern Italy. Int. J. Food Microbiol. 82:2003;281-287
6. Fallon R., O'Sullivan N., Maher M., Carroll C. Antimicrobial resistance of Campylobacter jejuni and Campylobacter coli isolates from broiler chickens isolated at an Irish poultry processing plant. Lett. Appl. Microbiol. 36:2003;277-281
7. Padungton P., Kaneene J.B. Campylobacter spp. in human, chickens, pigs and their antimicrobial resistance. J. Vet. Med. Sci. 65:2003;161-170
8. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin. Infect. Dis. 34:2002;482-492
9. Vacher S., Menard A., Bernard E., Megraud F. PCR-Restriction fragment length polymorphism analysis for detection of point mutations associated with macrolide resistance in Campylobacter spp. Antimicrob. Agents Chemother. 47:2003;1125-1128
10. Niwa H., Chuma T., Okamoto K., Itoh K. Rapid detection of mutations associated with resistance to erythromycin in Campylobacter jejuni/coli by PCR and line probe assay. Int. J. Antimicrob. Agents. 18:2001;359-364
11. Jensen L.B., Aarestrup F.M. Macrolide resistance in Campylobacter coli of animal origin in Denmark. Antimicrob. Agents Chemother. 45:2001;371-372
12. Trieber C.A., Taylor D.E. 23S rRNA mutations and macrolide resistance in Campylobacter. Int. J. Med. Microbiol. 291:2001;295
13. Drlica K., Zhao X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol. Mol. Biol. Rev. 61:1997;377-392
14. Ruiz J. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J. Antimicrob. Chemother. 51:2003;1109-1117
15. Zirnstein G., Helsel L., Li Y., Swaminathan B., Besser J. Characterization of gyrA mutations associated with fluoroquinolone resistance in Campylobacter coli by DNA sequence analysis and MAMA PCR. FEMS Microbiol. Lett. 190:2000;1-7
16. Wang Y., Huang W.M., Taylor D.E. Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations. Antimicrob. Agents Chemother. 37:1993;457-463
17. Bachoual R., Ouabdesselam S., Mory F., Lascols C., Soussy C.J., Tankovic J. Single or double mutational alterations of gyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli. Microb. Drug Resist. 7:2001;257-261
18. Cooper R., Segal H., Lastovica A.J., Elisha B.G. Genetic basis of quinolone resistance and epidemiology of resistant and susceptible isolates of porcine Campylobacter coli strains. J. Appl. Microbiol. 93:2002;241-249
19. Payot S., Cloeckaert A., Chaslus-Dancla E. Selection and characterization of fluoroquinolone-resistant mutants of Campylobacter jejuni using enrofloxacin. Microb. Drug Resist. 8:2002;335-343
20. Piddock L.J., Ricci V., Pumbwe L., Everett M.J., Griggs D.J. Fluoroquinolone resistance in Campylobacter species from man and animals: detection of mutations in topoisomerase genes. J. Antimicrob. Chemother. 51:2003;19-26
21. Pumbwe L., Piddock L.J. Identification and molecular characterisation of CmeB, a Campylobacter jejuni multidrug efflux pump. FEMS Microbiol. Lett. 206:2002;185-189
22. Lin J., Michel L.O., Zhang Q. CmeABC functions as a multidrug efflux system in Campylobacter jejuni. Antimicrob. Agents Chemother. 46:2002;2124-2131
23. Luo N., Sahin O., Lin J., Michel L.O., Zhang Q. in vivo selection of Campylobacter isolates with high levels of fluoroquinolone resistance associated with gyrA mutations and the function of the CmeABC efflux pump. Antimicrob. Agents Chemother. 47:2003;390-394
24. Baucheron S., Imberechts H., Chaslus-Dancla E., Cloeckaert A. The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar Typhimurium phage type DT204. Microb. Drug Resist. 8:2002;281-289
25. Lomovskaya O., Warren M.S., Lee A., et al. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob. Agents Chemother. 45:2001;105-116
26. Mazzariol A., Tokue Y., Kanegawa T.M., Cornaglia G., Nikaido H. High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA. Antimicrob. Agents Chemother. 44:2000;3441-3443
27. Renau T.E., Leger R., Flamme E.M., et al. Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin. J. Med. Chem. 42:1999;4928-4931
28. Avrain L., Humbert F., L'hospitalier R., Sanders P., Kempf I. Antimicrobial resistance in Campylobacter from broilers. Br. Poult. Sci. 42:2001;S32-S43
29. Parkhill J., Wren B.W., Mungall K., et al. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature. 403:2000;665-668
30. Members of the SFM Antibiogram Committee. Comité de l'antibiogramme de la Société Française de Microbiologie Report 2003. Int J Antimicrob Agents 21;2003:364-91.
31. Lomovskaya O., Watkins W. Inhibition of efflux pumps as a novel approach to combat drug resistance in bacteria. J. Mol. Microbiol. Biotechnol. 3:2001;225-236